Inventor · disambiguated record
Daniel Scherman
Also filed as: SCHERMAN DANIEL
38 granted patents·12 pending applications·767 citations·filing 1995–2020
98Inventor score
Top patents by PatentIndex Score
50 records- 0193US6939862B2Method for transferring nucleic acid into striated musclesROUSSY INST GUSTAVE·Filed 2001·Granted Sep 6, 2005·114 cites·30 claims
- 0288US6013240ANucleic acid containing composition, preparation and uses of sameRHONE POULENC RORER SA·Filed 1995·Granted Jan 11, 2000·127 cites·34 claims
- 0387US6492164B1Circular DNA expression cassettes for gene transferAVENTIS PHARMA SA·Filed 2000·Granted Dec 10, 2002·17 cites·10 claims
- 0486US9487782B2Methods for the treatment of leber congenital amaurosisROZET JEAN-MICHEL·Filed 2014·Granted Nov 8, 2016·9 cites·4 claims
- 0586US7038026B2Purification of a triple heli formation with an immobilized oligonucleotideCENTELION·Filed 2001·Granted May 2, 2006·10 cites·33 claims
- 0684US7622566B2Purification of a triple helix formation with an immobilized oligonucleotideCENTELION·Filed 2005·Granted Nov 24, 2009·3 cites·2 claims
- 0784US5945400ANucleic acid-containing composition, preparation and use thereofRHONE POULENC RORER SA·Filed 1996·Granted Aug 31, 1999·65 cites·34 claims
- 0882US9012425B2Methods for the treatment of Leber congenital amaurosisROZET JEAN-MICHEL·Filed 2012·Granted Apr 21, 2015·6 cites·1 claims
- 0982US6143530ACircular DNA expression cassettes for in vivo gene transferRHONE POULENC RORER SA·Filed 1996·Granted Nov 7, 2000·71 cites·43 claims
- 1082US6107286ALipopolyamines as transfection agents and pharamaceutical uses thereofRHONE POULENC RORER SA·Filed 1995·Granted Aug 22, 2000·69 cites·25 claims
- 1181US9777272B2Methods for the treatment of Leber congenital amaurosisROZET JEAN-MICHEL·Filed 2016·Granted Oct 3, 2017·3 cites·4 claims
- 1280US10597654B2Methods for the treatment of Leber congenital amaurosisROZET JEAN MICHEL·Filed 2017·Granted Mar 24, 2020·1 cites·2 claims
- 1379US6200956B1Nucleic acid-containing composition, preparation and use thereofAVENTIS PHARMA SA·Filed 1999·Granted Mar 13, 2001·40 cites·36 claims
- 1478US8709383B2Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imagingSCHERMAN DANIEL·Filed 2006·Granted Apr 29, 2014·5 cites·12 claims
- 1578US8017744B2Purification of a triple helix formation with an immobilized oligonucleotideCENTELION·Filed 2009·Granted Sep 13, 2011·1 cites·6 claims
- 1677US9474782B2Use of decorin for increasing muscle massASS FRANCAISE CONTRE LES MYOPATHIES·Filed 2013·Granted Oct 25, 2016·4 cites·20 claims
- 1777US6300321B1Compounds, preparation and use for transferring nucleic acids into cellsAVENTIS PHARMA SA·Filed 1998·Granted Oct 9, 2001·53 cites·35 claims
- 1874US6521252B1Transfecting compounds which are sensitive to reducing conditions, pharmaceutical compositions containing them and their applicationsAVENTIS PHARMA SA·Filed 2000·Granted Feb 18, 2003·7 cites·30 claims
- 1973US6171612B1Lipopolyamines as transfection agents and pharmaceutical uses thereofAVENTIS PHARMA SA·Filed 1996·Granted Jan 9, 2001·38 cites·34 claims
- 2071US7641914B2Acid-sensitive compounds, their preparation and usesGENCELL SA·Filed 2005·Granted Jan 5, 2010·1 cites·13 claims
- 2170US11492621B2Methods for the treatment of Leber congenital amaurosisINST NAT SANTE RECH MED·Filed 2020·Granted Nov 8, 2022·0 cites·8 claims
- 2269US8440455B2Plasmic production and expression of recombinant proteins in cells grown without antibioticsSCHERMAN DANIEL·Filed 2008·Granted May 14, 2013·3 cites·6 claims
- 2368US8039445B2Methods and devices for delivering a therapeutic product to the ocular sphere of a subjectINST NAT SANTE RECH MED·Filed 2006·Granted Oct 18, 2011·10 cites·22 claims
- 2466US6528315B2Method for transferring nucleic acid into multicelled eukaryotic organism cells and combination thereforAVENTIS PHARMA SA·Filed 1998·Granted Mar 4, 2003·24 cites·46 claims
- 2565US6172048B1Composition containing nucleic acids, preparation and usesAVENTIS PHARMA SA·Filed 1998·Granted Jan 9, 2001·19 cites·30 claims
- 2664US6319672B1Purification of a triple helix formation with an immobilized oligonucleotideAVENTIS PHARMA SA·Filed 2000·Granted Nov 20, 2001·16 cites·21 claims
- 2762US6825341B2Process for preparing functionalized polyalkyleneimines, compositions containing them and uses thereofGENCELL SA·Filed 2001·Granted Nov 30, 2004·8 cites·16 claims
- 2862US6812218B2Lipid derivatives of polythioureaGENCELL SA·Filed 2002·Granted Nov 2, 2004·1 cites·58 claims
- 2961US6287762B1Purification of a triple helix formation with an immobilized oligonucleotideRHONE POULENC RORER SA·Filed 1995·Granted Sep 11, 2001·18 cites·41 claims
- 3060US8399636B2Purification of a triple helix formation with an immobilized obligonucleotideCROUZET JOEL·Filed 2011·Granted Mar 19, 2013·0 cites·16 claims
- 3159US9877653B2Persistent luminescence nanoparticles excitable in situ for in vivo optical imaging, in vivo multimodal optical—MRI imaging, and theranosticsCENTRE NATIONAL DE LA RECHERCHE SCIENT (CNRS)·Filed 2013·Granted Jan 30, 2018·3 cites·19 claims
- 3259US2003104444A1Circular DNA expression cassettes for gene transferAVENTIS PHARMA SA·Filed 2002·Application pending·0 cites
- 3355US5846947AComposition containing nucleic acids, preparation and usesRHONE POULENC RORER SA·Filed 1995·Granted Dec 8, 1998·11 cites·22 claims
- 3455US2007255041A1Bioengineered Vehicles for Targeted Nucleic Acid DeliveryHUSTON JAMES S·Filed 2007·Application pending·0 cites
- 3553US9540425B2Vaccines against pregnancy-associated malariaNDAM NICAISE TUIKUE·Filed 2011·Granted Jan 10, 2017·1 cites·10 claims
- 3653US5821038AYeast with modified permeabilityRHONE POULENC RORER SA·Filed 1995·Granted Oct 13, 1998·9 cites·13 claims
- 3751US2002132990A1Bioengineered vehicles for targeted nucleic acid deliveryFiled 2001·Application pending·0 cites
- 3851US2012058955A1Use of decorine for increasing muscle massKICHLER ANTOINE·Filed 2010·Application pending·0 cites
- 3949US2005289658A1System for regulating in vivo the expression of a transgene by conditional inhibitionGENCELL SA·Filed 2005·Application pending·0 cites
- 4048US2010129371A1Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said methodCENTRE NAT RECH SCIENT·Filed 2006·Application pending·0 cites
- 4147US9175055B2Use of fibromodulin and lumican for increasing muscle massASS FR CONTRE LES MYOPATHIES·Filed 2012·Granted Nov 3, 2015·0 cites·14 claims
- 4245US2020368373A1Optical imaging agents targeting inflammationUNIV SORBONNE·Filed 2019·Application pending·0 cites
- 4345US2002166132A1System for regulating in vivo the expression of a transgene by conditional inhibitionFiled 2001·Application pending·0 cites
- 4442US2006009403A1Dna demethylase antisense and chemotherapy combinationCENTRE NAT RECH SCIENT·Filed 2003·Application pending·0 cites
- 4541US2002091242A1Acid-sensitive compounds, their preparation and usesFiled 2001·Application pending·0 cites
- 4635US11291630B2Gelling compositions for treating malignant tumours and/or preventing tumour recurrenceCENTRE NAT RECH SCIENT·Filed 2016·Granted Apr 5, 2022·0 cites·6 claims
- 4735US2003105048A1Oligobenzimidazole derivatives and their use as DNA transfecting agentsFiled 2002·Application pending·0 cites
- 4829US9783547B2Water soluble 4-azapodophyllotoxin analogsCENTRE NAT DE LA RECH SCIENT (CNRS)·Filed 2015·Granted Oct 10, 2017·0 cites·18 claims
- 4926US2005085426A1Acid-sensitive compounds, preparation and use thereofFiled 2001·Application pending·0 cites
- 5025US9572776B2Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acidsESCRIOU VIRGINIE·Filed 2010·Granted Feb 21, 2017·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Scherman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →